Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs. Brands. ... which emerged from Google DeepMind in 2021, ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes ...

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough in medicine. The company is gearing up to begin human clinical trials for drugs designed ...

Google's artificial intelligence company DeepMind has developed a breakthrough AI system that learns in a similar way to a human in order to prevent "catastrophic forgetting." ...

Google DeepMind CEO Demis Hassabis. Researchers at the AI lab have just put out a paper saying that human-like "artificial general intelligence" could arrive by 2030 and pose an existential risk ...

The mission of Google’s DeepMind Technologies startup is to “solve intelligence.” Now, researchers there have developed an artificial intelligence system that can mimic some of the brain’s ...